IRON
insider transactionsDisc Medicine, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-85.5K
0 buy · 85.5K sell
Net value · 365d
-$5.7M
$0 in · $5.7M out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
21
0 buy · 85.5K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
13.4K sh
Own +72%
-
Exercise·M
Chief Operating Officer · 10b5-1
$0
5.3K sh
Own New
-
Sell·S
Chief Operating Officer · 10b5-1
$486.7K
7.0K sh · $69.92
Own -11%
-
Sell·S
Chief Operating Officer · 10b5-1
$801.1K
11.7K sh · $68.76
Own -16%
-
Exercise·M
Chief Operating Officer · 10b5-1
$131.6K
13.4K sh · $9.86
Own +22%
-
Exercise·M
Chief Operating Officer · 10b5-1
$51.9K
5.3K sh · $9.86
Own +10%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$433.2K
6.3K sh · $69.24
Own -9%
-
Sell·S
Chief Medical Officer · 10b5-1
$147.0K
2.2K sh · $66.81
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$233.5K
3.5K sh · $66.12
Own -4%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$27.6K
400 sh · $69.00
Own -1%
-
Sell·S
Chief Medical Officer · 10b5-1
$198.3K
3.0K sh · $66.41
Own -3%
-
Sell·S
Chief Medical Officer · 10b5-1
$287.8K
4.4K sh · $65.52
Own -5%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$24.4K
353 sh · $69.06
Own -0%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$242.7K
3.7K sh · $65.89
Own -5%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$220.8K
3.4K sh · $65.01
Own -4%
-
Sell·S
Chief Legal Officer
$179.3K
2.9K sh · $62.86
Own -5%
-
Sell·S
Chief Commercial Officer
$347.7K
5.5K sh · $62.86
Own -6%
-
Sell·S
Chief Medical Officer
$204.7K
3.3K sh · $62.86
Own -3%
-
Sell·S
Chief Operating Officer
$203.1K
3.2K sh · $62.86
Own -6%
-
Sell·S
John D Quisel KEY
Chief Executive Officer
$833.8K
13.3K sh · $62.86
Own -6%
-
Sell·S
Jean M. Franchi KEY
Chief Financial Officer · 10b5-1
$256.2K
4.1K sh · $62.86
Own -5%
-
Grant·A
Chief Legal Officer
$0
25.5K sh
Own New
-
Grant·A
Chief Legal Officer
$0
17.0K sh
Own +45%
-
Grant·A
Chief Commercial Officer
$0
25.5K sh
Own New
-
Grant·A
Chief Commercial Officer
$0
17.0K sh
Own +24%
-
Grant·A
Chief Medical Officer
$0
25.5K sh
Own New
-
Grant·A
Chief Medical Officer
$0
17.0K sh
Own +22%
-
Grant·A
Chief Operating Officer
$0
25.5K sh
Own New
-
Grant·A
Chief Operating Officer
$0
17.0K sh
Own +42%
-
Grant·A
Jean M. Franchi KEY
Chief Financial Officer
$0
25.5K sh
Own New
-
Grant·A
Jean M. Franchi KEY
Chief Financial Officer
$0
19.0K sh
Own +30%
-
Grant·A
John D Quisel KEY
Chief Executive Officer
$0
82.8K sh
Own New
-
Grant·A
John D Quisel KEY
Chief Executive Officer
$0
55.2K sh
Own +30%
-
Exercise·M
Chief Legal Officer · 10b5-1
$0
1.0K sh
Own +5%
-
Sell·S
Chief Legal Officer · 10b5-1
$69.7K
1.0K sh · $69.74
Own -3%
-
Exercise·M
Chief Legal Officer · 10b5-1
$13.5K
1.0K sh · $13.50
Own +3%
-
Exercise·M
Chief Legal Officer · 10b5-1
$0
6.5K sh
Own +41%
-
Sell·S
Chief Legal Officer · 10b5-1
$91.7K
1.2K sh · $79.27
Own -3%
-
Sell·S
Chief Legal Officer · 10b5-1
$392.6K
5.0K sh · $78.62
Own -11%
-
Sell·S
Chief Legal Officer · 10b5-1
$27.2K
350 sh · $77.67
Own -1%
-
Exercise·M
Chief Legal Officer · 10b5-1
$87.8K
6.5K sh · $13.50
Own +17%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Exercise M | 13.4K | $0 |
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Exercise M | 5.3K | $0 |
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Sell S | 7.0K | $486.7K |
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Sell S | 11.7K | $801.1K |
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Exercise M | 13.4K | $131.6K |
| Jun 16, 2026 | Jonathan Yen-Wen Yu 10b5-1 | Exercise M | 5.3K | $51.9K |
| Apr 14, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 6.3K | $433.2K |
| Apr 13, 2026 | William Jacob Savage 10b5-1 | Sell S | 2.2K | $147.0K |
| Apr 13, 2026 | William Jacob Savage 10b5-1 | Sell S | 3.5K | $233.5K |
| Apr 13, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 400 | $27.6K |
| Mar 2, 2026 | William Jacob Savage 10b5-1 | Sell S | 3.0K | $198.3K |
| Mar 2, 2026 | William Jacob Savage 10b5-1 | Sell S | 4.4K | $287.8K |
| Feb 25, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 353 | $24.4K |
| Feb 18, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 3.7K | $242.7K |
| Feb 18, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 3.4K | $220.8K |
| Feb 17, 2026 | Rahul Khara | Sell S | 2.9K | $179.3K |
| Feb 17, 2026 | Pamela Stephenson | Sell S | 5.5K | $347.7K |
| Feb 17, 2026 | William Jacob Savage | Sell S | 3.3K | $204.7K |
| Feb 17, 2026 | Jonathan Yen-Wen Yu | Sell S | 3.2K | $203.1K |
| Feb 17, 2026 | John D Quisel KEY | Sell S | 13.3K | $833.8K |
| Feb 17, 2026 | Jean M. Franchi KEY 10b5-1 | Sell S | 4.1K | $256.2K |
| Feb 10, 2026 | Rahul Khara | Grant A | 25.5K | $0 |
| Feb 10, 2026 | Rahul Khara | Grant A | 17.0K | $0 |
| Feb 10, 2026 | Pamela Stephenson | Grant A | 25.5K | $0 |
| Feb 10, 2026 | Pamela Stephenson | Grant A | 17.0K | $0 |
| Feb 10, 2026 | William Jacob Savage | Grant A | 25.5K | $0 |
| Feb 10, 2026 | William Jacob Savage | Grant A | 17.0K | $0 |
| Feb 10, 2026 | Jonathan Yen-Wen Yu | Grant A | 25.5K | $0 |
| Feb 10, 2026 | Jonathan Yen-Wen Yu | Grant A | 17.0K | $0 |
| Feb 10, 2026 | Jean M. Franchi KEY | Grant A | 25.5K | $0 |
| Feb 10, 2026 | Jean M. Franchi KEY | Grant A | 19.0K | $0 |
| Feb 10, 2026 | John D Quisel KEY | Grant A | 82.8K | $0 |
| Feb 10, 2026 | John D Quisel KEY | Grant A | 55.2K | $0 |
| Jan 20, 2026 | Rahul Khara 10b5-1 | Exercise M | 1.0K | $0 |
| Jan 20, 2026 | Rahul Khara 10b5-1 | Sell S | 1.0K | $69.7K |
| Jan 20, 2026 | Rahul Khara 10b5-1 | Exercise M | 1.0K | $13.5K |
| Jan 2, 2026 | Rahul Khara 10b5-1 | Exercise M | 6.5K | $0 |
| Jan 2, 2026 | Rahul Khara 10b5-1 | Sell S | 1.2K | $91.7K |
| Jan 2, 2026 | Rahul Khara 10b5-1 | Sell S | 5.0K | $392.6K |
| Jan 2, 2026 | Rahul Khara 10b5-1 | Sell S | 350 | $27.2K |
| Jan 2, 2026 | Rahul Khara 10b5-1 | Exercise M | 6.5K | $87.8K |
About IRON insider trading
This page tracks insider transactions for Disc Medicine, Inc. (IRON) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.